Case 4-2005: A 35-year-old man with nasal congestion, swelling, and pain

New England Journal of Medicine

Volumn 352, Issue 6, 2005, Pages 609-615

  Weller, Peter F ^a   Durand, Marlene L ^a,b   Pilch, Ben Z ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACITRACIN; CEFALEXIN; LEVOFLOXACIN; ANTIMONY GLUCONATE; ANTITRYPANOSOMAL AGENT;

ADULT; ANAMNESIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EDEMA; EMERGENCY WARD; FOLLOW UP; HUMAN; LABORATORY DIAGNOSIS; MALE; NOSE CAVITY; NOSE CONGESTION; NOSE DISEASE; NOSE SEPTUM; NOSE ULCER; PAIN; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEUS MIRABILIS; ANIMAL; BIOPSY; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; LEISHMANIA BRAZILIENSIS; NOSE; NOSE OBSTRUCTION; PARASITOLOGY; PATHOLOGY; SKIN LEISHMANIASIS;

ADULT; ANIMALS; ANTIMONY SODIUM GLUCONATE; BIOPSY; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, MUCOCUTANEOUS; MALE; NASAL OBSTRUCTION; NOSE; NOSE DISEASES; PAIN; TRYPANOCIDAL AGENTS;

EID: 13744260398     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcpc049035     Document Type: Article

References (20)

1. Herwaldt BL. Leishmaniasis. Lancet 1999;354:1191-9.
2. Cutaneous leishmaniasis in U.S. military personnel - Southwest/Central Asia, 2002-2003. MMWR Morb Mortal Wkly Rep 2003;52:1009-12.
3. Pearson RD, Jeronimo SMD, Sousa AQ. Leishmaniasis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical infectious diseases: principles, pathogens & practice. Philadelphia: Churchill Livingstone, 1999:797-813.
4. Marsden PD. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans R Soc Trop Med Hyg 1986;80:859-76.
5. Berman JD. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 1997;24:684-703.
6. Scope A, Trau H, Bakon M, Yarom N, Nasereddin A, Schwartz E. Imported mucosal leishmaniasis in a traveler. Clin Infect Dis 2003;37:e83-e87.
7. Walton BC, Chinel LV, Eguīa y Eguia O. Onset of espundia after many years of occult infection with Leishmania braziliensis. Am J Trop Med Hyg 1973;22:696-8.
8. Pearson RD, Sousa AQ. Clinical spectrum of leishmaniasis. Clin Infect Dis 1996;22:1-13.
9. Saenz RE, de Rodriguez CG, Johnson CM, Berman JD. Efficacy and toxicity of pentostam against Panamanian mucosal leishmaniasis. Am J Trop Med Hyg 1991;44:394-8.
10. Almeida OP, Jacks JJr, Scully C. Paracoccidioidomycosis of the mouth: an emerging deep mycosis. Crit Rev Oral Biol Med 2003;14:377-83.
11. de Castro CC, Benard G, Ygaki Y, Shikanai-Yasuda M, Cerri GG. MRJ of head and neck paracoccidioidomycosis. Br J Radiol 1999;72:717-22.
12. Mota Sasaki M, Matsumo Carvalho M, Schmitz Ferreira ML, Machado MP. Cutaneous leishmaniasis coinfection in AIDS patients: case report and literature review. Braz J Infect Dis 1997;1:142-4.
13. Pirmez C, da Silva Trajano V, Paes-Oliveira Neto M, et al. Use of PCR in diagnosis of human American tegumentary leishmaniasis in Rio de Janeiro, Brazil. J Clin Microbiol 1999;37:1819-23.
14. Zajtchuk JT, Casler JD, Netto EM, et al. Mucosal leishmaniasis in Brazil. Laryngoscope 1989;99:925-39.
15. Protozoal infections. In: Weedon D. Skin pathology. 2nd ed. London: Churchill Livingstone, 2002:721-5.
16. Connor DH, Neafie RC. Cutaneous leishmaniasis. In: Binford CH, Connor DH, eds. Pathology of tropical and extraordinary diseases. Vol. 1. Washington, D.C.: Armed Forces Institute of Pathology, 1976:258-64.
17. Jha TK, Sundar S, Thakur CP, et al. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 1999;341:1795-800.
18. Soto J, Toledo J, Gutierrez P, et al. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis 2001;33:e57-e61.
19. Petzl-Erler ML, Belich MP, Queiroz-Telles F. Association of mucosal leishmaniasis with HLA. Hum Immunol 1991;32:254-60.
20. Bacellar O, Lessa H, Schriefer A, et al. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 2002;70:6734-40.